arg-pro-pro-gly-phe-ser-pro-leu acetate salt structure
|
Common Name | arg-pro-pro-gly-phe-ser-pro-leu acetate salt | ||
---|---|---|---|---|
CAS Number | 115035-45-5 | Molecular Weight | 930.06 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C43H67N11O12 | Melting Point | N/A | |
MSDS | USA | Flash Point | N/A |
Use of arg-pro-pro-gly-phe-ser-pro-leu acetate saltDes-Arg9-[Leu8]-Bradykinin acetate is potent bradykinin receptor 1 (B1R) antagonist. Des-Arg9-[Leu8]-Bradykinin acetate can be used for renal fibrosis research[1]. |
Name | arg-pro-pro-gly-phe-ser-pro-leu acetate salt |
---|---|
Synonym | More Synonyms |
Description | Des-Arg9-[Leu8]-Bradykinin acetate is potent bradykinin receptor 1 (B1R) antagonist. Des-Arg9-[Leu8]-Bradykinin acetate can be used for renal fibrosis research[1]. |
---|---|
Related Catalog | |
Target |
IC50: B1R[1] |
References |
Molecular Formula | C43H67N11O12 |
---|---|
Molecular Weight | 930.06 |
Exact Mass | 929.49700 |
PSA | 360.08000 |
LogP | 0.84570 |
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
Upregulation of B1 receptor mediating des-Arg9-BK-induced rat paw oedema by systemic treatment with bacterial endotoxin.
Br. J. Pharmacol. 117 , 793-798, (1996) 1. The effect of pretreatment with bacterial endotoxin (LPS, 10 micrograms, i.v., 24 h) on the bradykinin B1 and B2 receptor-induced oedema in the rat paw, and the interaction of B1-mediated responses... |
|
Angiotensin II type 2 receptor expression after vascular injury: differing effects of angiotensin-converting enzyme inhibition and angiotensin receptor blockade.
Hypertension 48 , 942-949, (2006) It has been suggested that the effects of angiotensin II type 1 receptor (AT1R) blockers are in part because of angiotensin II type 2 receptor (AT2R) signaling. Interactions between the AT2R and kinin... |
|
The role of kinin B1 receptors in the nociception produced by peripheral protein kinase C activation in mice.
Neuropharmacology 54 , 597-604, (2008) The peripheral injection of phorbol myristate acetate (PMA) into the mouse paw induces nociception mediated through activation of protein kinase C (PKC). In the present study, we examine the contribut... |
arg-pro-pro-gly-phe-ser-pro-leu acoh 3h2o |